Savara
SVRA
#6493
Rank
C$1.23 B
Marketcap
C$6.02
Share price
1.54%
Change (1 day)
-1.75%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2026 (TTM): -C$0.2 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -C$0.17 Billion a decrease over its 2024 earnings that were of -C$0.14 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.2 Billion16.39%
2025 -C$0.17 Billion23.94%
2024 -C$0.14 Billion75.29%
2023 -C$76.84 Million43.38%
2022 -C$53.59 Million-11.31%
2021 -C$60.42 Million-13.3%
2020 -C$69.69 Million-36.53%
2019 -C$0.11 Billion13.76%
2018 -C$96.53 Million105.54%
2017 -C$46.97 Million34.11%
2016 -C$35.02 Million-37.43%
2015 -C$55.97 Million38.81%
2014 -C$40.32 Million33.62%
2013 -C$30.18 Million38.49%
2012 -C$21.79 Million24.59%
2011 -C$17.49 Million-36.5%
2010 -C$27.54 Million-3.14%
2009 -C$28.44 Million-23.28%
2008 -C$37.06 Million8.52%
2007 -C$34.15 Million-34.14%
2006 -C$51.86 Million184.43%
2005 -C$18.24 Million90.75%
2004 -C$9.56 Million190.35%
2003 -C$3.3 Million11.64%
2002 -C$2.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-C$0.12 Billion-42.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-C$25.51 Million-86.97%๐Ÿ‡บ๐Ÿ‡ธ USA